 |
 |

Growth Attenuation by Commission and Omission May Be Ethically Justifiable in Children With Profound Disabilities
Lainie Friedman Ross, MD, PhD
Arch Pediatr Adolesc Med. 2007;161(4):418.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Gunther and Diekema1 present a unique case report of a child with profound disabilities whose parents requested an active intervention to arrest growth to facilitate caregiving at home. More common is a child with profound disabilities whose annual growth rate is subnormal. In an otherwise healthy child, a workup would include growth hormone (GH) function studies, whereas with this child, the parents and physicians may choose not to test for GH function. In fact, I would argue that it is ethical for the physician to not even suggest a GH workup in this setting. It is not in the child's interest to undergo daily injections to attain larger stature both because of the child's inability to understand the need for the injections and the low likelihood of benefiting from the increased growth. If GH deficiency testing is offered by a physician, one could argue that . . . [Full Text of this Article]AUTHOR INFORMATION
RELATED ARTICLES
Attenuating Growth in Children With Profound Developmental Disability: A New Approach to an Old Dilemma
Daniel F. Gunther and Douglas S. Diekema
Arch Pediatr Adolesc Med. 2006;160(10):1013-1017.
ABSTRACT
| FULL TEXT
Growth Attenuation: A Diminutive Solution to a Daunting Problem
Jeffrey P. Brosco and Chris Feudtner
Arch Pediatr Adolesc Med. 2006;160(10):1077-1078.
EXTRACT
| FULL TEXT
|